Indoleamine 2, 3-dioxygenase (IDO) inhibitors and cancer immunotherapy

Y Fujiwara, S Kato, MK Nesline, JM Conroy… - Cancer treatment …, 2022 - Elsevier
Strategies for unlocking immunosuppression in the tumor microenvironment have been
investigated to overcome resistance to first-generation immune checkpoint blockade with …

The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease

V Rothhammer, FJ Quintana - Nature Reviews Immunology, 2019 - nature.com
The environment, diet, microbiota and body's metabolism shape complex biological
processes in health and disease. However, our understanding of the molecular pathways …

Regulation of the immune response by the aryl hydrocarbon receptor

C Gutiérrez-Vázquez, FJ Quintana - Immunity, 2018 - cell.com
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is
activated by small molecules provided by the diet, microorganisms, metabolism, and …

The gut–brain axis and the microbiome: mechanisms and clinical implications

V Osadchiy, CR Martin, EA Mayer - Clinical Gastroenterology and …, 2019 - Elsevier
Background & Aims Based largely on results from preclinical studies, the concept of a brain
gut microbiome axis has been established, mediating bidirectional communication between …

Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects

AAB Badawy - International journal of tryptophan research, 2017 - journals.sagepub.com
Regulatory and functional aspects of the kynurenine (K) pathway (KP) of tryptophan (Trp)
degradation are reviewed. The KP accounts for~ 95% of dietary Trp degradation, of which …

Tryptophan metabolism in inflammaging: from biomarker to therapeutic target

FJH Sorgdrager, PJW Naudé, IP Kema… - Frontiers in …, 2019 - frontiersin.org
Inflammation aims to restore tissue homeostasis after injury or infection. Age-related decline
of tissue homeostasis causes a physiological low-grade chronic inflammatory phenotype …

Targeting the IDO1 pathway in cancer: from bench to bedside

M Liu, X Wang, L Wang, X Ma, Z Gong… - Journal of hematology & …, 2018 - Springer
Abstract Indoleamine 2, 3-dioxygenases (IDO1 and IDO2) and tryptophan 2, 3-dioxygenase
(TDO) are tryptophan catabolic enzymes that catalyze the conversion of tryptophan into …

IL-6 in inflammation, immunity, and disease

T Tanaka, M Narazaki… - Cold Spring Harbor …, 2014 - cshperspectives.cshlp.org
Interleukin 6 (IL-6), promptly and transiently produced in response to infections and tissue
injuries, contributes to host defense through the stimulation of acute phase responses …

IDO1 in cancer: a Gemini of immune checkpoints

L Zhai, E Ladomersky, A Lenzen, B Nguyen… - Cellular & molecular …, 2018 - nature.com
Abstract Indoleamine 2, 3-dioxygenase 1 (IDO1) is a rate-limiting metabolic enzyme that
converts the essential amino acid tryptophan (Trp) into downstream catabolites known as …

The therapeutic potential of targeting tryptophan catabolism in cancer

CA Opitz, LF Somarribas Patterson… - British journal of …, 2020 - nature.com
Based on its effects on both tumour cell intrinsic malignant properties as well as anti-tumour
immune responses, tryptophan catabolism has emerged as an important metabolic regulator …